190 related articles for article (PubMed ID: 27388717)
1. IL-33 circulating serum levels are increased in patients with non-segmental generalized vitiligo.
Vaccaro M; Cicero F; Mannucci C; Calapai G; Spatari G; Barbuzza O; Cannavò SP; Gangemi S
Arch Dermatol Res; 2016 Sep; 308(7):527-30. PubMed ID: 27388717
[TBL] [Abstract][Full Text] [Related]
2. Enhanced Th1 and Th17 responses in peripheral blood in active non-segmental vitiligo.
Zhen Y; Yao L; Zhong S; Song Y; Cui Y; Li S
Arch Dermatol Res; 2016 Dec; 308(10):703-710. PubMed ID: 27687555
[TBL] [Abstract][Full Text] [Related]
3. Increased serum levels of interleukin-23 circulating in patients with non-segmental generalized vitiligo.
Vaccaro M; Cannavò SP; Imbesi S; Cristani M; Barbuzza O; Tigano V; Gangemi S
Int J Dermatol; 2015 Jun; 54(6):672-4. PubMed ID: 25427848
[TBL] [Abstract][Full Text] [Related]
4. Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: Correlation with disease activity.
Talaat RM; Mohamed SF; Bassyouni IH; Raouf AA
Cytokine; 2015 Apr; 72(2):146-53. PubMed ID: 25647269
[TBL] [Abstract][Full Text] [Related]
5. The role of helper and regulatory T cells in the pathogenesis of vitiligo.
Basak PY; Adiloglu AK; Ceyhan AM; Tas T; Akkaya VB
J Am Acad Dermatol; 2009 Feb; 60(2):256-60. PubMed ID: 19022528
[TBL] [Abstract][Full Text] [Related]
6. Interleukin 17, interleukin 22 and FoxP3 expression in tissue and serum of non-segmental vitiligo: a case- controlled study on eighty-four patients.
Elela MA; Hegazy RA; Fawzy MM; Rashed LA; Rasheed H
Eur J Dermatol; 2013; 23(3):350-5. PubMed ID: 23797460
[TBL] [Abstract][Full Text] [Related]
7. Cytokine profile (IL-2, IL-6, IL-17, IL-22, and TNF-α) in vitiligo-New insight into pathogenesis of disease.
Sushama S; Dixit N; Gautam RK; Arora P; Khurana A; Anubhuti A
J Cosmet Dermatol; 2019 Feb; 18(1):337-341. PubMed ID: 29504235
[TBL] [Abstract][Full Text] [Related]
8. T helper and regulatory T cell cytokine profile in active, stable and narrow band ultraviolet B treated generalized vitiligo.
Tembhre MK; Sharma VK; Sharma A; Chattopadhyay P; Gupta S
Clin Chim Acta; 2013 Sep; 424():27-32. PubMed ID: 23680073
[TBL] [Abstract][Full Text] [Related]
9. Increased circulating Th17 cells and elevated serum levels of TGF-beta and IL-21 are correlated with human non-segmental vitiligo development.
Zhou L; Shi YL; Li K; Hamzavi I; Gao TW; Huggins RH; Lim HW; Mi QS
Pigment Cell Melanoma Res; 2015 May; 28(3):324-9. PubMed ID: 25604047
[TBL] [Abstract][Full Text] [Related]
10. Acitretin exerted a greater influence on T-helper (Th)1 and Th17 than on Th2 cells in treatment of psoriasis vulgaris.
Niu X; Cao W; Ma H; Feng J; Li X; Zhang X
J Dermatol; 2012 Nov; 39(11):916-21. PubMed ID: 22913391
[TBL] [Abstract][Full Text] [Related]
11. Predominant role of innate pro-inflammatory cytokines in vitiligo disease.
Gholijani N; Yazdani MR; Dastgheib L
Arch Dermatol Res; 2020 Mar; 312(2):123-131. PubMed ID: 31620869
[TBL] [Abstract][Full Text] [Related]
12. Number of Circulating Follicular Helper 2 T Cells Correlates With IgG4 and Interleukin-4 Levels and Plasmablast Numbers in IgG4-Related Disease.
Akiyama M; Suzuki K; Yamaoka K; Yasuoka H; Takeshita M; Kaneko Y; Kondo H; Kassai Y; Miyazaki T; Morita R; Yoshimura A; Takeuchi T
Arthritis Rheumatol; 2015 Sep; 67(9):2476-81. PubMed ID: 25989153
[TBL] [Abstract][Full Text] [Related]
13. Role of T helper 17 cells in the pathogenesis of systemic lupus erythematosus.
Abou Ghanima AT; Elolemy GG; Ganeb SS; Abo Elazem AA; Abdelgawad ER
Egypt J Immunol; 2012; 19(2):25-33. PubMed ID: 23885404
[TBL] [Abstract][Full Text] [Related]
14. Effects of CO2 fractional laser therapy on peripheral blood cytokines in patients with vitiligo.
Hu Y; Qi X; Hu Y; Lu Y; Liu K; Han X; Mao Z; Wu Z; Zhou X
Dermatol Ther; 2019 Jul; 32(4):e12992. PubMed ID: 31172649
[TBL] [Abstract][Full Text] [Related]
15. A comparison of serum inflammatory cytokines according to phenotype in patients with psoriasis.
Choe YB; Hwang YJ; Hahn HJ; Jung JW; Jung HJ; Lee YW; Ahn KJ; Youn JI
Br J Dermatol; 2012 Oct; 167(4):762-7. PubMed ID: 22564054
[TBL] [Abstract][Full Text] [Related]
16. [An imbalance between Th1 and Th2-like cytokines in patients with autoimmune diseases--differential diagnosis between Th1 dominant autoimmune diseases and Th2 dominant autoimmune diseases].
Ishida H; Ota H; Yanagida H; Dobashi H
Nihon Rinsho; 1997 Jun; 55(6):1438-43. PubMed ID: 9200929
[TBL] [Abstract][Full Text] [Related]
17. Circulating Th1 and Th2 cytokines in patients with hepatitis C virus infection.
Fan XG; Liu WE; Li CZ; Wang ZC; Luo LX; Tan DM; Hu GL; Zhang Z
Mediators Inflamm; 1998; 7(4):295-7. PubMed ID: 9792341
[TBL] [Abstract][Full Text] [Related]
18. Circulating CCL20: A potential biomarker for active vitiligo together with the number of Th1/17 cells.
Zhang L; Kang Y; Chen S; Wang L; Jiang M; Xiang L
J Dermatol Sci; 2019 Feb; 93(2):92-100. PubMed ID: 30655106
[TBL] [Abstract][Full Text] [Related]
19. Serum Levels of IL-33 and Correlation with IL-4, IL-17A, and Hypergammaglobulinemia in Patients with Autoimmune Hepatitis.
Liang M; Liwen Z; Yun Z; Yanbo D; Jianping C
Mediators Inflamm; 2018; 2018():7964654. PubMed ID: 30034292
[TBL] [Abstract][Full Text] [Related]
20. Role of interleukin-17 in the pathogenesis of vitiligo.
Bassiouny DA; Shaker O
Clin Exp Dermatol; 2011 Apr; 36(3):292-7. PubMed ID: 21198791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
